vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($331.0M vs $270.4M, roughly 1.2× Enhabit, Inc.). INTERFACE INC runs the higher net margin — 7.1% vs -14.3%, a 21.4% gap on every dollar of revenue. On growth, INTERFACE INC posted the faster year-over-year revenue change (11.3% vs 4.7%). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -2.3%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
EHAB vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $331.0M |
| Net Profit | $-38.7M | $23.6M |
| Gross Margin | — | 38.3% |
| Operating Margin | -12.3% | 9.8% |
| Net Margin | -14.3% | 7.1% |
| Revenue YoY | 4.7% | 11.3% |
| Net Profit YoY | 15.9% | 81.5% |
| EPS (diluted) | $-0.76 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $331.0M | ||
| Q4 25 | $270.4M | $349.4M | ||
| Q3 25 | $263.6M | $364.5M | ||
| Q2 25 | $266.1M | $375.5M | ||
| Q1 25 | $259.9M | $297.4M | ||
| Q4 24 | $258.2M | $335.0M | ||
| Q3 24 | $253.6M | $344.3M | ||
| Q2 24 | $260.6M | $346.6M |
| Q1 26 | — | $23.6M | ||
| Q4 25 | $-38.7M | $24.4M | ||
| Q3 25 | $11.1M | $46.1M | ||
| Q2 25 | $5.2M | $32.6M | ||
| Q1 25 | $17.8M | $13.0M | ||
| Q4 24 | $-46.0M | $21.8M | ||
| Q3 24 | $-110.2M | $28.4M | ||
| Q2 24 | $-200.0K | $22.6M |
| Q1 26 | — | 38.3% | ||
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% |
| Q1 26 | — | 9.8% | ||
| Q4 25 | -12.3% | 10.1% | ||
| Q3 25 | 6.4% | 14.6% | ||
| Q2 25 | 6.3% | 13.9% | ||
| Q1 25 | 6.1% | 7.8% | ||
| Q4 24 | -16.0% | 8.8% | ||
| Q3 24 | -38.6% | 12.3% | ||
| Q2 24 | 4.3% | 11.0% |
| Q1 26 | — | 7.1% | ||
| Q4 25 | -14.3% | 7.0% | ||
| Q3 25 | 4.2% | 12.7% | ||
| Q2 25 | 2.0% | 8.7% | ||
| Q1 25 | 6.8% | 4.4% | ||
| Q4 24 | -17.8% | 6.5% | ||
| Q3 24 | -43.5% | 8.3% | ||
| Q2 24 | -0.1% | 6.5% |
| Q1 26 | — | $0.40 | ||
| Q4 25 | $-0.76 | $0.41 | ||
| Q3 25 | $0.22 | $0.78 | ||
| Q2 25 | $0.10 | $0.55 | ||
| Q1 25 | $0.35 | $0.22 | ||
| Q4 24 | $-0.92 | $0.38 | ||
| Q3 24 | $-2.20 | $0.48 | ||
| Q2 24 | $0.00 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $61.2M |
| Total DebtLower is stronger | $426.0M | $196.5M |
| Stockholders' EquityBook value | $534.0M | $634.6M |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | 0.80× | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $61.2M | ||
| Q4 25 | $43.6M | $71.3M | ||
| Q3 25 | $56.9M | $187.4M | ||
| Q2 25 | $37.1M | $121.7M | ||
| Q1 25 | $39.5M | $97.8M | ||
| Q4 24 | $28.4M | $99.2M | ||
| Q3 24 | $45.7M | $115.6M | ||
| Q2 24 | $28.5M | $94.2M |
| Q1 26 | — | $196.5M | ||
| Q4 25 | $426.0M | $181.6M | ||
| Q3 25 | $441.5M | $307.8M | ||
| Q2 25 | $456.9M | $304.4M | ||
| Q1 25 | $467.3M | $302.9M | ||
| Q4 24 | $492.6M | $302.8M | ||
| Q3 24 | $502.9M | $337.9M | ||
| Q2 24 | $512.7M | $387.6M |
| Q1 26 | — | $634.6M | ||
| Q4 25 | $534.0M | $640.7M | ||
| Q3 25 | $566.8M | $621.0M | ||
| Q2 25 | $552.4M | $575.0M | ||
| Q1 25 | $543.2M | $513.1M | ||
| Q4 24 | $523.5M | $489.1M | ||
| Q3 24 | $566.1M | $501.6M | ||
| Q2 24 | $674.3M | $451.2M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | — | 0.31× | ||
| Q4 25 | 0.80× | 0.28× | ||
| Q3 25 | 0.78× | 0.50× | ||
| Q2 25 | 0.83× | 0.53× | ||
| Q1 25 | 0.86× | 0.59× | ||
| Q4 24 | 0.94× | 0.62× | ||
| Q3 24 | 0.89× | 0.67× | ||
| Q2 24 | 0.76× | 0.86× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | — |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.4M | $49.3M | ||
| Q3 25 | $37.8M | $76.7M | ||
| Q2 25 | $10.6M | $30.1M | ||
| Q1 25 | $17.9M | $11.7M | ||
| Q4 24 | $-4.1M | $38.0M | ||
| Q3 24 | $28.4M | $76.2M | ||
| Q2 24 | $9.6M | $21.5M |
| Q1 26 | — | — | ||
| Q4 25 | $3.3M | $28.6M | ||
| Q3 25 | $36.2M | $66.1M | ||
| Q2 25 | $8.7M | $22.8M | ||
| Q1 25 | $17.6M | $4.3M | ||
| Q4 24 | $-4.7M | $24.4M | ||
| Q3 24 | $27.7M | $69.7M | ||
| Q2 24 | $8.9M | $12.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 8.2% | ||
| Q3 25 | 13.7% | 18.1% | ||
| Q2 25 | 3.3% | 6.1% | ||
| Q1 25 | 6.8% | 1.4% | ||
| Q4 24 | -1.8% | 7.3% | ||
| Q3 24 | 10.9% | 20.3% | ||
| Q2 24 | 3.4% | 3.5% |
| Q1 26 | — | 3.1% | ||
| Q4 25 | 0.4% | 5.9% | ||
| Q3 25 | 0.6% | 2.9% | ||
| Q2 25 | 0.7% | 2.0% | ||
| Q1 25 | 0.1% | 2.5% | ||
| Q4 24 | 0.2% | 4.1% | ||
| Q3 24 | 0.3% | 1.9% | ||
| Q2 24 | 0.3% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.02× | ||
| Q3 25 | 3.41× | 1.66× | ||
| Q2 25 | 2.04× | 0.93× | ||
| Q1 25 | 1.01× | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
TILE
| AMS | $195.7M | 59% |
| EAAA | $135.4M | 41% |
